^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Bladder Cancer
    Drug:alpha lactalbumin oleic acid (Alpha1H) (Apoptosis stimulant)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: B - Late Trials
    New
    Source:
    Hamlet BioPharma Press Release
    Title:

    Hamlet BioPharma receives U.S. FDA Fast Track designation for Alpha 1H for the treatment of non-muscle invasive bladder cancer

    Published date:
    11/29/2023
    Excerpt:
    Hamlet BioPharma...announces today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its drug candidate Alpha1H for the treatment of non-muscle invasive bladder cancer. The U.S. FDA Fast Track Designation accelerates the approval process for Alpha 1H and potential for reaching the US market.